Financial Statements 10 Auditors remuneration The fee charged for the statutory audit of the Company was 0.05m 2013: 0.05m.
11 related Party Transactions The Company has taken advantage of the exemption within Financial Reporting Standard No.
8 Related Party Disclosures not to disclose related party transactions with wholly owned subsidiaries of the Reckitt Benckiser Group.
There were no other related party transactions 2013: nil.
12 Contingent liabilities The Company has issued a guarantee to the Trustees of the Reckitt Benckiser Pension Fund covering the obligations of certain UK subsidiaries of the Group who are the sponsoring employers of the UK defined benefit pension fund.
The guarantee covers any amounts due to the pension fund from these subsidiaries if they fail to meet their pension obligations.
The Company has also issued a guarantee on behalf of Reckitt Benckiser Treasury Services plc in relation to the issuance of a US$1bn bond two tranches of US$500m.
Details are included in note 14 of the Group financial statements.
The Company has also issued other guarantees relating to subsidiary undertakings amounting to 1m 2013: 1m.
Other contingent liabilities are disclosed in note 19 of the Group financial statements.
13 dividends During 2014 the Directors declared an interim cash dividend of 60p 2013: 60p and proposed a final cash dividend of 79p 2013: 77p.
In addition on 23December 2014 the pharmaceutical business was demerged by means of a non-cash dividend, granting all Reckitt Benckiser Group plc ordinary Shareholders new shares in the newly formed Indivior PLC For further details, refer to note 28 of the Group financial statements.
14 Post Balance Sheet events On 11 February 2015, we announced our intention to supplement the current share buyback policy with an additional share buyback programme in 2015 of up to 500m.
This, combined with the previous share buyback programme announced in 2014, will absorb approximately 800m of Shareholders funds.
RB Annual Report and Financial Statements 2014 125
